Medical Marijuana for ALS and Terminal Conditions in Florida

ALS (amyotrophic lateral sclerosis) is one of the specifically named qualifying conditions for medical marijuana under Florida Statute 381.986. Terminal conditions — defined as conditions that, in a physician's reasonable medical judgment, will result in death within one year — also qualify.

For patients facing ALS or other terminal diagnoses, the conversation about medical cannabis isn't really about "treating" the disease. It's about quality of life. It's about managing pain, spasticity, appetite loss, insomnia, and the psychological burden of a devastating diagnosis. It's about comfort. And in this context, medical cannabis is one of the most versatile tools available.

ALS and Medical Cannabis

ALS progressively destroys motor neurons — the nerve cells that control voluntary movement. As the disease advances, patients lose the ability to move, speak, swallow, and eventually breathe. There is no cure, and the two FDA-approved medications (riluzole and edaravone) extend survival modestly but don't stop progression.

Medical cannabis doesn't slow ALS either. But it addresses multiple symptoms that significantly impact daily life:

Spasticity and Muscle Cramps

Spasticity — involuntary muscle tightness, stiffness, and cramping — is one of the most common and distressing ALS symptoms. It interferes with mobility, causes pain, disrupts sleep, and reduces overall comfort.

THC is an effective muscle relaxant. It acts on CB1 receptors in the spinal cord and brain to reduce the excessive nerve signaling that causes spasticity. For ALS patients, medical cannabis can provide meaningful relief from cramps and stiffness — often complementing or partially replacing conventional antispasmodic medications like baclofen or tizanidine, which can cause significant sedation and cognitive impairment.

Pain

Despite the common misconception that ALS is painless, research shows that 50-70% of ALS patients experience pain. Sources include muscle cramps, joint immobility, pressure sores, neuropathic pain, and the general discomfort of progressive weakness.

Medical cannabis addresses pain through both THC (central pain modulation) and CBD (peripheral anti-inflammatory effects). For many ALS patients, it provides pain relief with fewer cognitive side effects than opioid medications.

Appetite Loss and Weight Management

Maintaining caloric intake and body weight is critically important in ALS. Nutritional status is directly correlated with survival and quality of life. But ALS patients frequently experience appetite loss due to difficulty swallowing (dysphagia), fatigue from eating, depression, and medication side effects.

THC's appetite-stimulating effect is well-documented and can help ALS patients maintain nutrition for longer. This is particularly important before the patient transitions to a feeding tube — and even afterward, as appetite and enjoyment of food (for patients who can still eat some foods orally) contribute significantly to quality of life.

Sleep Disturbance

ALS disrupts sleep profoundly — through pain, spasticity, respiratory insufficiency, anxiety, and the emotional weight of the diagnosis. Poor sleep accelerates fatigue, cognitive decline, and mood deterioration.

Medical cannabis, particularly THC-dominant products used in the evening, can significantly improve sleep quality. For ALS patients dealing with nighttime cramps and spasticity, this improvement can be transformative.

Anxiety and Depression

The psychological impact of an ALS diagnosis is enormous. Depression and anxiety are common and understandable. While counseling and conventional psychiatric medications play important roles, medical cannabis — particularly balanced THC:CBD products — can provide additional relief from anxiety and improve mood.

Secretion Management

Excessive saliva (sialorrhea) is a common and socially debilitating ALS symptom. Interestingly, one of the common side effects of THC — dry mouth (xerostomia) — can actually be beneficial for ALS patients dealing with sialorrhea. This is an example of a "side effect" becoming a therapeutic benefit in the right clinical context.

Terminal Conditions Beyond ALS

Florida's statute qualifies any terminal condition — not just ALS — for medical marijuana. This includes but isn't limited to:

• Advanced cancer with a prognosis of less than one year
• End-stage COPD or pulmonary fibrosis
• Advanced heart failure
• End-stage renal or liver disease
• Advanced neurodegenerative diseases (certain stages of Parkinson's, Huntington's, etc.)

For patients with terminal diagnoses, the treatment framework shifts from disease management to comfort care. Medical cannabis fits naturally into this framework — reducing pain, improving appetite, supporting sleep, and easing anxiety without the cumulative toxicity of many pharmaceutical alternatives.

Special Considerations for ALS and Terminal Patients

Routes of Administration

As ALS progresses, the ability to use certain medical cannabis products changes:

Early stage: All routes are available — flower, edibles, tinctures, topicals, vaporizers. Patients should experiment during this period to find what works best.

Middle stage: Swallowing difficulty (dysphagia) may limit oral products. Sublingual tinctures (placed under the tongue rather than swallowed) may still be viable. Inhaled products remain an option if respiratory function is adequate. Topicals work for localized pain and spasticity.

Late stage: As motor function and swallowing decline further, sublingual tinctures, topical products, and suppositories may be the remaining options. Caregivers play an essential role in product administration during this stage.

Planning ahead — identifying products and routes that will work as the disease progresses — is important. Your physician should help you think through this trajectory.

Caregiver Cards

Most ALS and terminal patients will eventually need a caregiver to manage their medical cannabis. Florida's caregiver program allows a designated person (family member, friend, or aide) to purchase, transport, and administer medical cannabis on behalf of the patient.

The caregiver application requires:

• Being 21 or older
• Florida residency
• Passing a Level 2 background check
• A $75 application fee plus fingerprinting costs

The patient must be certified first, then the caregiver application can be submitted. Plan ahead — the background check can take several weeks.

Dosing Considerations

Terminal patients often require higher doses than other medical cannabis patients, and Florida law recognizes this. Physicians can order higher quantities for terminal patients, and in some cases, specific product types (like Rick Simpson Oil / RSO, which is very high in THC) may be appropriate for serious symptom management.

Start low and increase gradually, as with any patient. But don't be surprised if the therapeutic dose for a terminal patient is higher than typical starting doses — the symptom burden is often greater, and the priority is comfort.

Hospice Coordination

If the patient is receiving hospice care, communication between the medical marijuana physician, the hospice team, and the caregiver is important. Most hospice organizations are familiar with medical cannabis use and can coordinate care accordingly. Some hospice nurses are knowledgeable about cannabis products and can help with administration.

Note that hospice organizations vary in their policies regarding medical cannabis. If medical cannabis is an important part of the patient's comfort plan, discuss this with the hospice team early.

Getting Certified

ALS is explicitly listed as a qualifying condition. Terminal conditions also qualify with physician determination. The process:

1. Schedule a telehealth or in-person evaluation (telehealth is often preferable for patients with mobility limitations)
2. Discuss the diagnosis, symptoms, and current treatments
3. Receive certification (entered into the registry same day)
4. Complete the state application ($75 fee)
5. Establish a caregiver if needed
6. Begin purchasing from licensed dispensaries

For ALS patients specifically, Florida law allows for expanded product access and potentially higher quantity limits than standard certifications.

FAQ

Does medical marijuana help slow ALS progression?

There is no clinical evidence that medical cannabis slows ALS progression. Preclinical (laboratory) research has explored potential neuroprotective effects of cannabinoids, but this has not been demonstrated in human studies. Medical cannabis is used for symptom management and quality of life, not disease modification.

Can hospice patients use medical marijuana?

Yes. Hospice enrollment does not disqualify a patient from the medical marijuana program. However, coordination with the hospice team is important to ensure all care providers are aligned.

What if the patient can't attend a physician evaluation?

Telehealth evaluations are ideal for ALS and terminal patients who have difficulty traveling. The entire evaluation can be conducted via video call from the patient's home, hospital bed, or care facility. If the patient cannot communicate verbally, a caregiver can assist during the evaluation.

Is medical marijuana covered by insurance for terminal patients?

No. Medical marijuana is not covered by any insurance plan for any condition. The evaluation fee, state card fee, and all dispensary purchases are out of pocket. Some dispensaries offer compassionate use discounts for terminal patients — ask about these programs.

How quickly can a terminal patient get their card?

The process can be expedited. The physician enters the certification same day, and the state application can often be processed quickly. In urgent situations, dispensaries may work with patients who have pending applications. Ask your physician and dispensary about expedited options.

Comfort Matters

When facing ALS or a terminal diagnosis, every tool that improves comfort, dignity, and quality of life matters. Medical cannabis won't change the prognosis — but it can meaningfully change the experience of living through it.

[Start the evaluation here](/start). Dr. Tae Y. Kim, DO, provides compassionate, same-day telehealth evaluations for ALS and terminal patients throughout Florida. Caregiver support is available for patients who need assistance.